Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMedicx Fund Regulatory News (MXF)

  • There is currently no data for MXF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - MedicX Fund Limited

8 Feb 2019 10:05

RNS Number : 4999P
Canaccord Genuity Limited
08 February 2019
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Canaccord Genuity Limited

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

MedicX Fund Limited

(c) Name of the party to the offer with which exempt principal trader is connected:

Connected party to the Offeree

 

(d) Date dealing undertaken:

7 February 2019

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

No

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

Ordinary NPV

 

Buy

 

 

35

 

 

88.8p

 

 

88.8p

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

Date of disclosure:

8 February 2019

Contact name:

Sam Holland

Telephone number:

020 7523 8337

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEREAEAPEELNEFF
Date   Source Headline
1st Apr 20111:51 pmRNSAllotment of scrip shares
30th Mar 20117:01 amRNSApproved acquisitions
30th Mar 20117:00 amRNSAdditional Listing
17th Mar 20113:06 pmRNSNotification of major interest in shares
14th Mar 20114:28 pmRNSDirector Declaration
14th Mar 20111:47 pmRNSNotification of major interest in shares
8th Mar 20119:54 amRNSNotification of major interest in shares
3rd Mar 201112:36 pmRNSNotification of major interest in shares
2nd Mar 20114:40 pmRNSResults of Issue
25th Feb 20117:00 amRNSPlacing / Open Offer / Offer for Subscription
24th Feb 20115:04 pmRNSResult of EGM
24th Feb 20115:03 pmRNSResult of AGM
23rd Feb 20115:06 pmRNSScrip Dividend Calculation Price
22nd Feb 20114:56 pmRNSCircular to Shareholders - Scrip Dividend Scheme
22nd Feb 20117:00 amRNSAcquisition of new primary care medical centre
15th Feb 20112:49 pmRNSNotice of quarterly dividend
15th Feb 20112:48 pmRNSAnnual Information Update
2nd Feb 201112:45 pmRNSProspectus Published
2nd Feb 201110:06 amRNSPlacing / Open Offer / Offer for Subscription
26th Jan 20118:57 amRNSInterim Management Statement
25th Jan 20115:35 pmRNSDirector Declaration
4th Jan 20117:00 amRNSAllotment of scrip shares to Chairman
4th Jan 20117:00 amRNSTotal Voting Rights
30th Dec 20107:00 amRNSAdditional Listing
8th Dec 20107:00 amRNSFull Year Results
24th Nov 20106:06 pmRNSScrip Dividend Scheme
23rd Nov 20106:17 pmRNSCircular to Shareholders - Scrip Dividend Scheme
19th Nov 20108:52 amRNSAcquisition of two new medical centres
18th Nov 20101:27 pmRNSTotal Voting Rights
18th Nov 20101:26 pmRNSIssue of new ordinary shares
11th Nov 20104:12 pmRNSBlock listing six monthly return
11th Nov 20107:00 amRNSQuarterly Net Asset Valuation
4th Oct 201012:52 pmRNSTotal Voting Rights
4th Oct 201012:50 pmRNSAllotment of scrip shares
29th Sep 20101:04 pmRNSAdditional Listing
27th Sep 20101:51 pmRNSNotification of major interest in shares
6th Sep 20101:14 pmRNSNotification of major interest in shares
3rd Sep 201011:25 amRNSNotification of Major Interest in Shares
2nd Sep 20105:13 pmRNSIssue of new ordinary shares
2nd Sep 20105:12 pmRNSTotal Voting Rights
25th Aug 20105:19 pmRNSScrip Dividend Scheme
23rd Aug 20101:44 pmRNSNotification Of Major Interest In Shares
23rd Aug 201012:34 pmRNSPublication of Circular
20th Aug 20109:28 amRNSNotification of Major Interest In Shares
19th Aug 201010:02 amRNSNotification of Major Interest In Shares
12th Aug 20107:00 amRNSInterim Management Statement
11th Aug 201011:58 amRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
10th Aug 201011:43 amRNSIssue of new ordinary shares
21st Jul 20101:18 pmRNSAcquisition of new primary care medical centre
5th Jul 20109:15 amRNSAcquisition of new primary care medical centre

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.